Specialists are debating calls to employ developmental medicines against an Ebola outbreak ravaging West Africa, the Canadian Press reports.
A number of analysts said distributing vaccines or drug treatments that are not fully tested may boost local distrust of officials that have been fighting the spread of Ebola hemorrhagic fever since March, the news agency reported on Wednesday. No fully vetted medicines currently exist for the disease, which as of Tuesday may have killed more than 500 people in Guinea, Liberia and Sierra Leone.
According to some opponents of using such medicines, any adverse side effects may threaten years of efforts to develop the drugs as a defense against the potential biological-weapon agent.
“It would be unethical to roll [developmental medicines] out now, in my opinion,” said David Heymann, a former World Health Organization assistant director general.
Officials could instead move, once the current threat subsides, to lay the groundwork for using such treatments to combat future outbreaks, Heymann argued. The World Health Organization could make such policy preparations in collaboration with drug developers and regional governments, he said.
One expert, though, pressed for immediately using Ebola countermeasures now in a late stage of development.
“Imagine if you take a region of Canada, America, Europe and you had 450 people dying of a viral hemorrhagic fever. It would just be unacceptable — and it’s unacceptable in West Africa,” said Jeremy Farrar, a tropical medicine and global health specialist at Oxford University.
What We're Following See More »
"Centrist Emmanuel Macron and far-right politician Marine Le Pen led the first round of voting in France’s presidential election, according to early projections, as voters redrew the political map, placing the European Union at the center of a new political divide. Projections by the Kantar-Sofres polling firm showed Mr. Macron on track to win the first round with about 24% of the vote, ahead of Ms. Le Pen with nearly 22%." The vote marks the end of the country's dominance by conservative and socialist parties. The top vote-getters head to a runoff on May 7.
President Trump will deliver the keynote address for at the National Holocaust Museum's National Day of Remembrance ceremony on Tuesday. He'll speak from the Capitol Rotunda. The move is likely an effort to try to mend fences with Jewish groups. In January, "the White House ignited controversy when it didn't mention Jews or anti-Semitism in a statement on International Holocaust Remembrance Day." And certain members of his inner circle are still suspected of harboring white supremacist or anti-Semitic views."
"President Trump and his top aides applied new pressure Sunday on lawmakers to include money for a wall on the U.S.-Mexico border in a must-pass government funding bill, raising the possibility of a federal government shutdown this week. In a pair of tweets, Trump attacked Democrats for opposing the wall and insisted that Mexico would pay for it “at a later date,” despite his repeated campaign promises not including that qualifier. And top administration officials appeared on Sunday morning news shows to press for wall funding, including White House budget director Mick Mulvaney, who said Trump might refuse to sign a spending bill that does not include any."
A Russian government think tank run by Putin loyalists "developed a plan to swing the 2016 U.S. presidential election to Donald Trump and undermine voters’ faith in the American electoral system." Two confidential documents from the Putin-backed Institute for Strategic Studies, obtained by U.S. intelligence, provide "the framework and rationale for what U.S. intelligence agencies have concluded was an intensive effort by Russia to interfere with the Nov. 8 election."
"The FBI last year used a dossier of allegations of Russian ties to Donald Trump's campaign as part of the justification" to monitor Carter Page, who was then a defense adviser to the Trump campaign. "The dossier has also been cited by FBI Director James Comey in some of his briefings to members of Congress in recent weeks."